Company ProSomnus, Inc.

Equities

OSAPQ

US50535E1082

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 12:09:40 2024-06-20 pm EDT			5-day change	1st Jan Change
0.0119 ^USD	-0.83%		-52.40%	-98.79%

May. 24	Joint Reorganization Plan and Disclosure Statement Filed by ProSomnus, Inc.	CI
May. 20	ProSomnus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Business Summary

ProSomnus, Inc. is a medical technology company. The Company is focused on the development, manufacturing and marketing of precision intraoral medical devices, a novel non-invasive option for treating and managing patients with obstructive sleep apnea (OSA). Its intraoral medical devices are engineered to precisely track the treatment plan and anatomy for each patient. The Company's devices have demonstrated efficacy, safety, adherence, and overall outcomes in a growing body of clinical investigations. Its precision intraoral devices are FDA-cleared, patented, and covered by commercial medical insurance, Medicare, TRICARE and many Government-sponsored healthcare plans around the world, representing over 200 million covered lives. The Companyâs products include ProSomnus EVO Sleep and Snore Device, ProSomnus EVO SELECT Sleep and Snore Device, ProSomnus EVO [PH] Sleep and Snore Device, ProSomnus [CA] LP Sleep and Snore Device and ProSomnus [MOG] Morning Occlusal Guide.

Number of employees: 136

Sales per Business

USD in Million	2022	Weight	2023	Weight	Delta
Precision Intraoral Medical Devices 100.0 %	19	100.0 %	28	100.0 %	+42.59%

Sales per region

USD in Million	2022	Weight	2023	Weight	Delta
North America and Europe 100.0 %	19	100.0 %	28	100.0 %	+42.59%

Managers

Managers	Title	Age	Since
Leonard Liptak FOU	Founder	50	22-05-02
Sung Kim FOU	Founder	43	22-05-02
Brian Dow DFI	Director of Finance/CFO	55	23-02-28

Members of the board

Members of the board	Title	Age	Since
William Johnson BRD	Director/Board Member	67	22-12-31
Leonard Hedge BRD	Director/Board Member	54	-
Steven Pacelli BRD	Director/Board Member	53	-
Laing Rikkers CHM	Chairman	54	22-05-02
Heather Rider BRD	Director/Board Member	64	-
Jason Orchard BRD	Director/Board Member	48	-
Leonard Liptak FOU	Founder	50	22-05-02

Share class

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	17,394,064	15,293,306 ( 87.92 %)	0	87.92 %

Shareholders

Name	Equities	%	Valuation
HealthpointCapital LLC 37.68 %	6,553,664	37.68 %	222 825 $
Spring Mountain Capital LP /Private Equity/ 20.39 %	3,546,068	20.39 %	120 566 $
Laing Rikkers 3.308 %	575,342	3.308 %	19 562 $
Forbes Financial Planning, Inc. 2.677 %	465,710	2.677 %	15 834 $
Leonard Liptak 2.677 %	465,710	2.677 %	15 834 $
Polar Asset Management Partners, Inc. 2.224 %	386,872	2.224 %	13 154 $
Sung Kim 1.017 %	176,897	1.017 %	6 014 $
Brian Dow 0.7868 %	136,848	0.7868 %	4 653 $
Wells Fargo Bank NA 0.6728 %	117,019	0.6728 %	3 979 $
Vanguard Group, Inc. (Subfiler) 0.5870 %	102,103	0.5870 %	3 472 $

Name	Equities	%	Valuation
Laing Rikkers 6.155 %	200,000	6.155 %	6 800 $
Leonard Liptak 1.539 %	50,000	1.539 %	1 700 $
Spring Mountain Capital LP /Private Equity/ 0.0296 %	961	0.0296 %	33 $
Brian Dow 0.001539 %	50	0.001539 %	2 $

Name	Equities	%	Valuation
Walleye Capital LLC -	706,365	-	3 532 $
Periscope Capital, Inc. -	542,468	-	2 712 $
Walleye Trading LLC -	397,325	-	1 987 $
Cowen & Co. LLC -	281,571	-	1 408 $
Polar Asset Management Partners, Inc. -	251,724	-	1 259 $
Arena Capital Advisors LLC -	187,500	-	938 $
Altium Capital Management LP -	150,000	-	750 $
Crossingbridge Advisors LLC -	123,109	-	616 $
Shaolin Capital Management LLC -	112,113	-	561 $
Aristides Capital LLC -	101,250	-	506 $